BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27137985)

  • 1. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
    Chandan VS; Shah SS; Torbenson MS; Wu TT
    Hum Pathol; 2016 Sep; 55():11-6. PubMed ID: 27137985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
    Terracciano LM; Glatz K; Mhawech P; Vasei M; Lehmann FS; Vecchione R; Tornillo L
    Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma.
    Giedl J; Büttner-Herold M; Wach S; Wullich B; Hartmann A; Agaimy A
    Hum Pathol; 2016 Sep; 55():101-7. PubMed ID: 27184483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
    Shahid M; Mubeen A; Tse J; Kakar S; Bateman AC; Borger D; Rivera MN; Ting DT; Deshpande V
    Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature.
    Haninger DM; Kloecker GH; Bousamra Ii M; Nowacki MR; Slone SP
    Mod Pathol; 2014 Apr; 27(4):535-42. PubMed ID: 24030743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA.
    Supriatna Y; Kishimoto T; Uno T; Nagai Y; Ishikura H
    Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin gene expression in adenocarcinomas with hepatoid differentiation.
    Foschini MP; Baccarini P; Dal Monte PR; Sinard J; Eusebi V; Rosai J
    Virchows Arch; 1998 Dec; 433(6):537-41. PubMed ID: 9870687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA; Ahmed NS
    Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of arginase-1 expression in distinguishing hepatocellular carcinoma from non-hepatocellular tumors].
    Sang W; Gulinar A; Wang CH; Sheng WQ; Maiweilidan Y; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):538-42. PubMed ID: 24246920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
    Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
    Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
    Arora K; Bal M; Shih A; Moy A; Zukerberg L; Brown I; Liu X; Kelly P; Oliva E; Mullen J; Ahn S; Kim KM; Deshpande V
    J Clin Pathol; 2018 Mar; 71(3):221-227. PubMed ID: 28814568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoid Teratoma, Hepatoid Yolk Sac Tumor, and Hepatocellular Carcinoma: A Morphologic and Immunohistochemical Study of 30 Cases.
    Al-Obaidy KI; Williamson SR; Shelman N; Idrees MT; Ulbright TM
    Am J Surg Pathol; 2021 Jan; 45(1):127-136. PubMed ID: 32991342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma.
    Krings G; Ramachandran R; Jain D; Wu TT; Yeh MM; Torbenson M; Kakar S
    Mod Pathol; 2013 Jun; 26(6):782-91. PubMed ID: 23348905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.
    Timek DT; Shi J; Liu H; Lin F
    Am J Clin Pathol; 2012 Aug; 138(2):203-10. PubMed ID: 22904131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.
    Clark I; Shah SS; Moreira R; Graham RP; Wu TT; Torbenson MS; Chandan V
    Hum Pathol; 2017 Nov; 69():90-95. PubMed ID: 28970136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase-1: a highly specific marker separating pancreatic adenocarcinoma from hepatocellular carcinoma.
    Fatima N; Cohen C; Siddiqui MT
    Acta Cytol; 2014; 58(1):83-8. PubMed ID: 24281232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.
    Yan BC; Gong C; Song J; Krausz T; Tretiakova M; Hyjek E; Al-Ahmadie H; Alves V; Xiao SY; Anders RA; Hart JA
    Am J Surg Pathol; 2010 Aug; 34(8):1147-54. PubMed ID: 20661013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma).
    Roberts CC; Colby TV; Batts KP
    Mayo Clin Proc; 1997 Dec; 72(12):1154-60. PubMed ID: 9413299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoid carcinoma of the ovary: a report of three cases admixed with a common surface epithelial carcinoma.
    Tochigi N; Kishimoto T; Supriatna Y; Nagai Y; Nikaido T; Ishikura H
    Int J Gynecol Pathol; 2003 Jul; 22(3):266-71. PubMed ID: 12819394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach.
    Sentani K; Oue N; Sakamoto N; Arihiro K; Aoyagi K; Sasaki H; Yasui W
    Mod Pathol; 2008 Apr; 21(4):464-75. PubMed ID: 18204429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.